 |
| Global Preventive Healthcare Technologies And Services Market Growth |
The Global Preventive Healthcare Technologies And Services Market comprises
products and solutions that assist in health risk assessment, disease
screening, lifestyle management, and provide preventive care to reduce the risk
of chronic diseases. Preventive healthcare technologies include devices and
solutions such as cancer screening, vaccination, early detection and prevention
of infectious diseases, lifestyle coaching, dietary supplements, and equipment
for risk assessment of cardiovascular, dental and vision screening.
The Global
Preventive Healthcare Technologies And Services Market is estimated to be
valued at US$ 556.64 Bn in 2024 and is expected to exhibit a CAGR of 10. % over
the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Global
Preventive Healthcare Technologies And Services Market Growth are
Healthlane, Abbott, GSK plc, Myriad Genetics, Omron Healthcare Inc., Quest
Diagnostics, Pfizer, Inc., Merck & Co., Inc., Omnicell, Novx Systems,
Corp., U-Systems, Ltd., Viatronix, Inc., Scripto LLC, Lifecom, Inc., Dilon
Medical Technologies, Inc., and McKesson Corporation. The growing needs for
early diagnosis and treatment of chronic diseases along with rising healthcare
costs have boosted the demand for preventive healthcare solutions globally.
Technological advancements in health risk assessment tools, genetic testing,
nutrition monitoring, and digital health solutions have enabled improved
disease prevention and patient outcomes.
Market trends
The market is witnessing increasing adoption of digital health solutions such
as mobile health apps, telehealth, and remote patient monitoring devices for
preventive care. Furthermore, block chain technology is gaining traction for
securely storing and sharing patients’ health records to enable collaboration
between payers, providers and life sciences companies. The use of AI and
analytics is also growing to generate personalized prevention plans and predict
disease risk levels based on patients’ genetic profiles and lifestyle
behaviors.
Market Opportunities
The rising geriatric population vulnerable to chronic diseases and government
initiatives to promote preventive healthcare present significant growth
opportunities. Developing economies in Asia Pacific and Latin America with
growing medical capabilities and healthcare expenditures represent lucrative
markets. Innovation of integrated solutions combining personalized genetic
screening, digital tools, and clinical programs can enable superior disease
prevention and management.
The impact of COVID-19 on the global preventive healthcare technologies and
services market:
The COVID-19 pandemic severely impacted the growth of the global preventive
healthcare technologies and services market. During the initial outbreak, focus
shifted away from preventive care towards testing, treatment, and vaccine
development for COVID-19. Regular checkups, health screenings, and routine
medical exams were postponed or delayed to avoid overburdening the healthcare
system. This led to a decline in demand for preventive healthcare services in
2020. However, as the pandemic intensified awareness about the importance of a
strong immune system and overall well-being increased. People recognized that
prioritizing preventive care is crucial to build resilience against viruses. As
restrictions eased in 2021, the market is witnessing a rebound as individuals
are now more inclined towards preventive healthcare to reduce susceptibility to
infections.
Key players are focusing on developing novel solutions for remote patient
monitoring, digital health records, prescription management, chronic disease
management, vaccinations, and telehealth/virtual consultations. The growing
application of digital technologies, wearables, apps, telemedicine is helping
provide contactless preventive services and bridging the gap caused due to
lockdowns. Market players are also expanding global partnerships and
collaborations to accelerate vaccine research and scale-up production.
Governments worldwide are implementing initiatives to strengthen public health
infrastructure, pandemic preparedness, expand health insurance coverage which
will boost long-term sustainable growth of this market in the post-COVID era.
In terms of value, North America dominated the preventive healthcare
technologies and services market in 2024, accounting for over 35% share. Strong
economic conditions, rapid technological advancements, growing chronic disease
burden, and favorable healthcare policies have propelled market growth in the
region. Asia Pacific is projected as the fastest growing market during the
forecast period. Rising medical expenditures, increasing focus on lifestyle
diseases, growing middle-class population, and improving access to services are
some major factors fueling market expansion in Asia Pacific countries like
China and India.
Europe captures the second largest market share and countries like Germany,
U.K., France are major revenue generators. Presence of stringent regulations
driving adoption of personalized medicine approaches and digitization is aiding
market growth in Europe. On the other hand, Latin America and Middle East &
Africa represent immense untapped opportunities. Initiatives by private and
public organizations to enhance public health outcomes through preventive care
adoption in these developing countries will further stimulate future demand.
Get More Insights On This Topic: Preventive
Healthcare Technologies And Services Market